MICHAEL HOLMES: Open Payments
NPI 1760544621 · HARRIMAN, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$314 in 15 payments from 9 companies in 2025. Trend: 2023 $590 · 2024 $353 · 2025 $314
Food & beverage: $314
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $72 |
| AstraZeneca Pharmaceuticals LP | 3 | $63 |
| Novo Nordisk Inc | 2 | $50 |
| ABBVIE INC. | 2 | $37 |
| Axsome Therapeutics, Inc. | 1 | $24 |
| Sumitomo Pharma America, Inc. | 1 | $22 |
| Phathom Pharmaceuticals, Inc. | 1 | $17 |
| Vanda Pharmaceuticals Inc. | 1 | $15 |
| Janssen Pharmaceuticals, Inc | 1 | $13 |
Products named: CAPLYTA, AIRSUPRA, VRAYLAR, Wegovy, Auvelity, GEMTESA, VOQUEZNA, HETLIOZ.
Industry payments across TN — which companies pay providers there.
